# OnCo record raajit-rampal (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/raajit-rampal/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "raajit-rampal" ;
  schema:name "Raajit K. Rampal"@en ;
  schema:description "New York haematologist who led MANIFEST-2, the trial testing whether adding the BET inhibitor pelabresib to ruxolitinib helps people with myelofibrosis more than ruxolitinib alone."@en ;
  schema:url <https://onco.cc/people/raajit-rampal/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "mpn", "trialist" ;
  schema:jobTitle "Haematologist, Memorial Sloan Kettering Cancer Center" ;
  schema:sameAs <https://orcid.org/0000-0002-0355-6368> ;
  onco:cancers <https://onco.cc/cancers/primary-myelofibrosis/>, <https://onco.cc/cancers/myeloproliferative-neoplasms/> ;
  onco:institutions <https://onco.cc/institutions/mskcc/> ;
  onco:trials <https://onco.cc/trials/manifest-2/> ;
  schema:affiliation <https://onco.cc/institutions/mskcc/> .